See more : Salisbury Bancorp, Inc. (SAL) Income Statement Analysis – Financial Results
Complete financial analysis of Beleave Inc. (BLEVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beleave Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Warburg Pincus Capital Corporation I-A (WPCA-WT) Income Statement Analysis – Financial Results
- Wirtek A/S (WIRTEK.CO) Income Statement Analysis – Financial Results
- NextCure, Inc. (NXTC) Income Statement Analysis – Financial Results
- Kaap Agri Limited (KAL.JO) Income Statement Analysis – Financial Results
- momo.com Inc. (8454.TW) Income Statement Analysis – Financial Results
Beleave Inc. (BLEVF)
About Beleave Inc.
Beleave Inc. operates as a medical cannabis company in Canada. The company cultivates and sells medical and recreational cannabis products. It also operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner. The company sells its products through operating stores and online. Beleave Inc. is headquartered in Oakville, Canada.
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 375.53K | 808.09K | 1.12M | 1.53M | 1.32M | 1.22M | 1.37M | 1.24M | 1.17M | 1.32M | 1.23M |
| Cost of Revenue | 1.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 816.46K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 375.53K | 808.09K | 1.12M | 1.53M | 1.32M | 1.22M | 1.37M | 1.24M | 1.17M | 1.32M | 1.23M |
| Gross Profit Ratio | 34.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 11.96K | 150.85K | 18.66K | 56.10K | 81.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 20.17M | 9.50M | 7.97M | 2.80M | 328.20K | 38.56K | 54.77K | 74.94K | 521.18K | 717.72K | 878.65K | 1.57M | 1.41M | 1.13M | 1.21M | 978.67K | 1.23M | 1.70M | 1.49M |
| Selling & Marketing | 1.48M | 751.53K | 519.99K | 93.35K | 50.43K | 0.00 | 0.00 | 0.00 | 89.14K | 187.17K | 359.04K | 84.39K | 91.69K | 127.31K | 124.25K | 120.70K | 31.66K | 92.07K | 76.84K |
| SG&A | 21.65M | 10.25M | 8.49M | 2.89M | 378.62K | 38.56K | 54.77K | 74.94K | 610.32K | 904.90K | 1.24M | 1.65M | 1.51M | 1.25M | 1.33M | 1.10M | 1.26M | 1.79M | 1.57M |
| Other Expenses | 254.95K | -1.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -30.64K | -37.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 24.56M | 10.73M | 8.51M | 2.95M | 460.34K | 38.56K | 54.77K | 74.94K | 612.57K | 911.07K | 1.25M | 1.66M | 1.52M | 1.28M | 1.36M | 1.17M | 1.37M | 1.89M | 1.61M |
| Cost & Expenses | 26.12M | 10.73M | 8.51M | 2.95M | 460.34K | 38.56K | 54.77K | 74.94K | 612.57K | 911.07K | 1.25M | 1.66M | 1.52M | 1.28M | 1.36M | 1.17M | 1.37M | 1.89M | 1.61M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 128.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.49K | 3.97K | 2.03K | 2.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.90M | 327.05K | 46.59K | 44.51K | 50.01K | 0.00 | 0.00 | 0.00 | 2.24K | 6.18K | 8.31K | 10.74K | 14.02K | 20.46K | 29.89K | 70.37K | 105.50K | 97.97K | 40.71K |
| EBITDA | -20.59M | -10.22M | -8.46M | -2.90M | -410.34K | -38.56K | -54.77K | -74.94K | -237.29K | -96.81K | -205.31K | -123.00K | -183.37K | -36.25K | 39.17K | 137.08K | -96.41K | -474.83K | -334.14K |
| EBITDA Ratio | -867.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -62.53% | -16.64% | -18.33% | -8.05% | -13.87% | -2.97% | 2.85% | 11.09% | -8.26% | -36.06% | -27.12% |
| Operating Income | -23.49M | -10.55M | -8.51M | -2.95M | -460.34K | -38.56K | -54.77K | -74.94K | -239.53K | -915.05K | -127.94K | -133.74K | -197.38K | -56.71K | 9.28K | 66.71K | -201.91K | -572.80K | -374.85K |
| Operating Income Ratio | -989.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -63.79% | -113.24% | -11.42% | -8.75% | -14.93% | -4.65% | 0.68% | 5.40% | -17.30% | -43.50% | -30.42% |
| Total Other Income/Expenses | -10.30M | -2.05M | -46.59K | -44.51K | -50.01K | 0.00 | 0.00 | 0.00 | -52.09K | -95.30K | -87.71K | 203.10K | 41.28K | 66.69K | -8.46K | -3.20K | -102.21K | 0.00 | 0.00 |
| Income Before Tax | -33.78M | -12.64M | -8.55M | -2.99M | -510.35K | -38.56K | -54.77K | 0.00 | -291.63K | -202.26K | -215.65K | 69.35K | -156.10K | 9.98K | 823.00 | 63.51K | -304.12K | 0.00 | 0.00 |
| Income Before Tax Ratio | -1,423.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -77.66% | -25.03% | -19.25% | 4.54% | -11.81% | 0.82% | 0.06% | 5.14% | -26.06% | 0.00% | 0.00% |
| Income Tax Expense | 383.03K | 183.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 74.94K | 2.49K | -33.74K | -85.68K | 2.49K | 2.50K | 1.79K | 0.00 | 0.00 | 3.48K | 2.37K | 3.31K |
| Net Income | -33.78M | -12.64M | -8.55M | -2.99M | -510.35K | -38.56K | -54.77K | -74.94K | -291.63K | -202.26K | -215.65K | 69.35K | -156.10K | 9.98K | 823.00 | 63.51K | -307.60K | -575.17K | -378.16K |
| Net Income Ratio | -1,423.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -77.66% | -25.03% | -19.25% | 4.54% | -11.81% | 0.82% | 0.06% | 5.14% | -26.36% | -43.68% | -30.69% |
| EPS | -0.08 | -0.05 | -0.06 | -0.03 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.08 | -0.05 | -0.06 | -0.03 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 409.22M | 239.28M | 150.92M | 96.72M | 88.06M | 82.78M | 73.09M | 33.78M | 33.78M | 33.78M | 101.34M | 101.34M | 100.17M | 88.04M | 83.81M | 83.46M | 78.83M | 75.61M | 60.13M |
| Weighted Avg Shares Out (Dil) | 409.22M | 239.28M | 150.92M | 96.72M | 88.06M | 82.78M | 73.09M | 33.78M | 33.78M | 33.78M | 101.34M | 101.34M | 100.17M | 88.04M | 83.81M | 83.46M | 78.83M | 75.61M | 60.13M |
No news found for: BLEVF
Source: https://incomestatements.info
Category: Stock Reports